Olive Diagnostics AI Urine Analysis Readable on The Apple Watch
Jerusalem-based Olive Diagnostics’s KG system is the world’s first 100 percent passive non-invasive real-time urine analysis sensor that can be hooked up to any toilet. This
KAHR Published Preclinical Data Indicating Treatment Potential of Their Anti-CD47 Fusion Protein
KAHR, a Jerusalem clinical-stage cancer immunotherapy company, has just announced the publication of their preclinical data that supports the development of DSP107. DSP107 is a
Salignostics Closes $8M Funding Round to Take Its Saliva-Based Pregnancy Test to Market
Salignostics, a Jerusalem medical startup, has raised $8 million in a Series A financing round in order to mass market their rapid saliva-based test kits.
Nectin Therapeutics Obtained $5.4 Million Investment for Solid Tumors Immunotherapy Study
Nectin Therapeutics Ltd., a biotechnology company developing novel targeted immunotherapies, and Cancer Focus Fund, LP, a unique investment fund established in collaboration with The University
NewStem Files FDA Pre-Submission & EMA IVDD for Revolutionary Cancer Diagnostic Device
NewStem Ltd filed for a pre-submission to the FDA for a De Novo Request and an in vitro cancer diagnostic device (IVDD) to the EMA
Nanox Opens So. Korean Fab Plant to Produce Semiconductor Chips for Novel Digital Nanox.ARC 3D X-Ray System
Nanox (Nasdaq/TASE: ), an Israeli corporation that has developed the first solid-state digital X-ray source designed to be used in real-world medical imaging applications, has
Oramed Granted NASH Patent in Europe
Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that the European Patent Office
Synthetic Biology Startup Seevix Material Sciences Starts Global Marketing Campaign for its Tissue Engineering Scaffold
HUMAN TISSUE REGENERATION IS SEEVIX’S ULTIMATE GOAL Seevix Material Sciences Ltd. is a privately-held biotech company producing high-strength SVX™, a state-of-the-art biopolymer material, inspired by
BiondVax Signs Expanded Agreement with Max Planck Society to Develop Nanosized Antibody Therapies
BiondVax Pharmaceuticals Ltd. (Nasdaq:BVXV), a Jerusalem based biopharmaceutical company focused on developing, manufacturing, and commercializing innovative products for the prevention and treatment of infectious diseases
